Review

Pharmacogenomics of adverse drug reactions

Ann K Daly

Genome Medicine 2013, 5:5 (29 January 2013)

Ann Daly reviews progress in identification of pharmacogenomic risk factors for serious adverse drug reactions, including different approaches used, and prospects for further progress.

Subscription required

All research articles in Genome Medicine are open access. The journal also publishes a range of other articles that are available to subscribers.

Existing subscribers

Forgotten your password? help